<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00683774</url>
  </required_header>
  <id_info>
    <org_study_id>VCU IRB 4479</org_study_id>
    <secondary_id>2R01HD035629-09A2</secondary_id>
    <nct_id>NCT00683774</nct_id>
  </id_info>
  <brief_title>Insulin and Polycystic Ovary Syndrome</brief_title>
  <official_title>Determination if Direct Inhibition of Insulin Release With Diazoxide Decreases Renal Clearance of D-Chiroinositol (DCI) and Increases Circulating DCI in Obese Women With Polycystic Ovary Syndrome (PCOS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increased insulin levels leads to increased secretion of D-chiro inositol(DCI) from the
      kidneys in women with PCOS, but not in normal women. This leads to a reduction in circulating
      DCI and insulin stimulated release of DCI-IPG.To determine if decreasing circulating insulin
      directly by inhibition of islet insulin release with diazoxide in obese women with PCOS
      1)decreases the renal clearance of DCI and 2) increases the circulating concentration of DCI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal Clearance of D-chiroinositol (DCI) at 12 Days</measure>
    <time_frame>12 days</time_frame>
    <description>Following inhibition of insulin release using diazoxide, measured renal clearance of D-chiro inositol (DCI) via urinary Chiro-inositol dci assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of Circulating D-chiro Inositol (DCI)</measure>
    <time_frame>12 days</time_frame>
    <description>Measured circulating concentration of plasma DCI following inhibition of insulin release using diazoxide</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>PCOS</condition>
  <arm_group>
    <arm_group_label>PCOS subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PCOS subjects given diazoxide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal subjects given diazoxide</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diazoxide</intervention_name>
    <description>100mg orally three times per day for 10 days</description>
    <arm_group_label>PCOS subjects</arm_group_label>
    <arm_group_label>Normal subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese women with PCOS and normal women aged 18-40,

          -  PCOS less than 8 periods/year, elevated total or free testosterone, normal thyroid
             function tests and serum prolactin, exclusion of adrenal hyperplasia

          -  Normal regular monthly periods, no clinical evidence of androgen excess,

          -  All Acceptable health on interview, medical history, physical exams and lab tests,
             signed, witnessed informed consent and ability to comply to study requirements

        Exclusion Criteria:

          -  DM, clinically significant pulmonary, cardiac, renal, hepatic, neurologic,
             psychiatric, infectious, neoplastic or malignant disease.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John E. Nestler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Clinical Research Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2008</study_first_submitted>
  <study_first_submitted_qc>May 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2008</study_first_posted>
  <results_first_submitted>May 30, 2014</results_first_submitted>
  <results_first_submitted_qc>August 19, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 21, 2014</results_first_posted>
  <last_update_submitted>June 9, 2017</last_update_submitted>
  <last_update_submitted_qc>June 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diazoxide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PCOS Subjects</title>
          <description>PCOS subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
        </group>
        <group group_id="P2">
          <title>Normal Subjects</title>
          <description>Normal subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Obese women with and without PCOS between the ages of 18-40 years selected after examination and eligibility screening</population>
      <group_list>
        <group group_id="B1">
          <title>PCOS Subjects</title>
          <description>PCOS subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
        </group>
        <group group_id="B2">
          <title>Normal Subjects</title>
          <description>Normal subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (Body Mass Index)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.0" lower_limit="32.7" upper_limit="49.2"/>
                    <measurement group_id="B2" value="38.4" lower_limit="33.3" upper_limit="43.4"/>
                    <measurement group_id="B3" value="39.7" lower_limit="32.7" upper_limit="49.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Waist-to-hip ratio (WHR)</title>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.84" lower_limit="0.81" upper_limit="0.88"/>
                    <measurement group_id="B2" value="0.78" lower_limit="0.72" upper_limit="0.84"/>
                    <measurement group_id="B3" value="0.81" lower_limit="0.72" upper_limit="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex hormone binding globulin (SHBG) (nmol/L)</title>
          <units>nmol/L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.1" lower_limit="23.3" upper_limit="44.2"/>
                    <measurement group_id="B2" value="45.6" lower_limit="33.7" upper_limit="61.7"/>
                    <measurement group_id="B3" value="38.9" lower_limit="23.3" upper_limit="61.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total testosterone (ng/mL)</title>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.2" lower_limit="1.2" upper_limit="3.8"/>
                    <measurement group_id="B2" value="1.1" lower_limit="0.6" upper_limit="1.8"/>
                    <measurement group_id="B3" value="1.7" lower_limit="0.6" upper_limit="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Free testosterone (pmol/L)</title>
          <units>pmol/L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144.3" lower_limit="73.1" upper_limit="285.1"/>
                    <measurement group_id="B2" value="57.7" lower_limit="30.4" upper_limit="109.6"/>
                    <measurement group_id="B3" value="101" lower_limit="30.4" upper_limit="285.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting glucose (mg/dl)</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85.3" lower_limit="80.7" upper_limit="89.9"/>
                    <measurement group_id="B2" value="84.2" lower_limit="77.9" upper_limit="90.5"/>
                    <measurement group_id="B3" value="84.8" lower_limit="77.9" upper_limit="90.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting insulin (ulU/mL)</title>
          <units>ulU/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.4" lower_limit="6.7" upper_limit="13.1"/>
                    <measurement group_id="B2" value="6.8" lower_limit="5.0" upper_limit="9.4"/>
                    <measurement group_id="B3" value="8.1" lower_limit="5.0" upper_limit="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Area under the curve (AUC) glucose (mg*min/dL)</title>
          <units>mg*min/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16447" lower_limit="15390" upper_limit="17504"/>
                    <measurement group_id="B2" value="13168" lower_limit="12209" upper_limit="14127"/>
                    <measurement group_id="B3" value="14808" lower_limit="12209" upper_limit="17504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>AUC insulin (mg*min/ml)</title>
          <units>mg*min/ml</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8351" lower_limit="4788" upper_limit="14568"/>
                    <measurement group_id="B2" value="5284" lower_limit="3127" upper_limit="8929"/>
                    <measurement group_id="B3" value="6818" lower_limit="3127" upper_limit="14568"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Whole Body Insulin Sensitivity Index</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.76" lower_limit="2.40" upper_limit="7.11"/>
                    <measurement group_id="B2" value="6.90" lower_limit="4.87" upper_limit="8.93"/>
                    <measurement group_id="B3" value="5.83" lower_limit="2.40" upper_limit="8.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Plasma DCI (nmol/mL)</title>
          <units>nmol/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.36" lower_limit="0.18" upper_limit="0.72"/>
                    <measurement group_id="B2" value="0.33" lower_limit="0.18" upper_limit="0.63"/>
                    <measurement group_id="B3" value="0.35" lower_limit="0.18" upper_limit="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>24-h urinary D-chiroinositol (DCI) (nmol/day)</title>
          <units>nmol/day</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1808" lower_limit="927" upper_limit="3527"/>
                    <measurement group_id="B2" value="1448" lower_limit="771" upper_limit="2719"/>
                    <measurement group_id="B3" value="1628" lower_limit="771" upper_limit="3527"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Urinary clearance (uCl) DCI (ml/min)</title>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.46" lower_limit="1.51" upper_limit="7.92"/>
                    <measurement group_id="B2" value="3.02" lower_limit="1.38" upper_limit="6.59"/>
                    <measurement group_id="B3" value="3.24" lower_limit="1.38" upper_limit="7.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Plasma myo-Inositol (MYO) (nmol/mL)</title>
          <units>nmol/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.7" lower_limit="15.9" upper_limit="23.4"/>
                    <measurement group_id="B2" value="23.1" lower_limit="18.9" upper_limit="27.3"/>
                    <measurement group_id="B3" value="21.4" lower_limit="15.9" upper_limit="27.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>24-h urinary MYO (nmol/day)</title>
          <units>nmol/day</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52866" lower_limit="32681" upper_limit="85519"/>
                    <measurement group_id="B2" value="78909" lower_limit="50140" upper_limit="124184"/>
                    <measurement group_id="B3" value="65888" lower_limit="32681" upper_limit="124184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>uCI MYO (ml/min)</title>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.91" lower_limit="1.30" upper_limit="2.81"/>
                    <measurement group_id="B2" value="2.43" lower_limit="1.69" upper_limit="3.49"/>
                    <measurement group_id="B3" value="2.17" lower_limit="1.30" upper_limit="3.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Renal Clearance of D-chiroinositol (DCI) at 12 Days</title>
        <description>Following inhibition of insulin release using diazoxide, measured renal clearance of D-chiro inositol (DCI) via urinary Chiro-inositol dci assay</description>
        <time_frame>12 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCOS Subjects</title>
            <description>PCOS subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
          </group>
          <group group_id="O2">
            <title>Normal Subjects</title>
            <description>Normal subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
          </group>
        </group_list>
        <measure>
          <title>Renal Clearance of D-chiroinositol (DCI) at 12 Days</title>
          <description>Following inhibition of insulin release using diazoxide, measured renal clearance of D-chiro inositol (DCI) via urinary Chiro-inositol dci assay</description>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.75" lower_limit="2.25" upper_limit="10.01"/>
                    <measurement group_id="O2" value="5.16" lower_limit="2.55" upper_limit="10.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Level of Circulating D-chiro Inositol (DCI)</title>
        <description>Measured circulating concentration of plasma DCI following inhibition of insulin release using diazoxide</description>
        <time_frame>12 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCOS Subjects</title>
            <description>PCOS subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
          </group>
          <group group_id="O2">
            <title>Normal Subjects</title>
            <description>Normal subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
          </group>
        </group_list>
        <measure>
          <title>Level of Circulating D-chiro Inositol (DCI)</title>
          <description>Measured circulating concentration of plasma DCI following inhibition of insulin release using diazoxide</description>
          <units>nmol/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" lower_limit="0.12" upper_limit="0.57"/>
                    <measurement group_id="O2" value="0.27" lower_limit="0.13" upper_limit="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PCOS Subjects</title>
          <description>PCOS subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
        </group>
        <group group_id="E2">
          <title>Normal Subjects</title>
          <description>Normal subjects given diazoxide
diazoxide: 100mg orally three times per day for 10 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. John Nestler</name_or_title>
      <organization>Virginia Commonwealth University</organization>
      <phone>804-828-3389</phone>
      <email>jnestler@mcvh-vcu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

